Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Biological Threats and Terrorism: Assessing The Science and Response Capabilities: Workshop Summary.

Institute of Medicine (US) Forum on Emerging Infections; Knobler SL, Mahmoud AAF, Pray LA, editors.

Washington (DC): National Academies Press (US); 2002.

2.

Overcoming Challenges to Develop Countermeasures Against Aerosolized Bioterrorism Agents: Appropriate Use of Animal Models.

National Research Council (US) Committee on Animal Models for Testing Interventions Against Aerosolized Bioterrorism Agents.

Washington (DC): National Academies Press (US); 2006.

3.

Discussion.

Glassman HN.

Bacteriol Rev. 1966 Sep;30(3):657-9. No abstract available.

4.
5.

Dosimetric comparisons of particle deposition and retention in rats and humans.

Brown JS, Wilson WE, Grant LD.

Inhal Toxicol. 2005 Jun-Jul;17(7-8):355-85.

PMID:
16020034
6.

Dosimetric adjustments for interspecies extrapolation of inhaled poorly soluble particles (PSP).

Jarabek AM, Asgharian B, Miller FJ.

Inhal Toxicol. 2005 Jun-Jul;17(7-8):317-34.

PMID:
16020031
7.

Non-human primate models for AIDS vaccine research.

Hu SL.

Curr Drug Targets Infect Disord. 2005 Jun;5(2):193-201. Review.

8.

Molecular basis for improved anthrax vaccines.

Brey RN.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1266-92. Epub 2005 Apr 21. Review.

PMID:
15935874
9.

Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis.

Brittingham KC, Ruthel G, Panchal RG, Fuller CL, Ribot WJ, Hoover TA, Young HA, Anderson AO, Bavari S.

J Immunol. 2005 May 1;174(9):5545-52.

10.

A nose-only apparatus for airborne delivery of Mycobacterium tuberculosis to mice: calibration of biological parameters.

Louveau C, Descroix D, Garnier L, Delamanche I, Chavarot P, Ramisse F, Marchal G, Vergnaud G.

Microbes Infect. 2005 Mar;7(3):457-66. Epub 2005 Mar 2.

PMID:
15792637
11.

Toward understanding the risk of secondary airborne infection: emission of respirable pathogens.

Nicas M, Nazaroff WW, Hubbard A.

J Occup Environ Hyg. 2005 Mar;2(3):143-54.

PMID:
15764538
12.

Predictive value of primate models for AIDS.

Haigwood NL.

AIDS Rev. 2004 Oct-Dec;6(4):187-98. Review.

PMID:
15700617
13.

Anthrax toxin: the long and winding road that leads to the kill.

Abrami L, Reig N, van der Goot FG.

Trends Microbiol. 2005 Feb;13(2):72-8. Review.

PMID:
15680766
14.

Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.

Flick-Smith HC, Waters EL, Walker NJ, Miller J, Stagg AJ, Green M, Williamson ED.

Microb Pathog. 2005 Jan;38(1):33-40. Epub 2004 Dec 19.

PMID:
15652293
15.

Demand for nonhuman primate resources in the age of biodefense.

Patterson JL, Carrion R Jr.

ILAR J. 2005;46(1):15-22. Review.

PMID:
15644560
16.

Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines.

Phipps AJ, Premanandan C, Barnewall RE, Lairmore MD.

Microbiol Mol Biol Rev. 2004 Dec;68(4):617-29. Review.

17.

Value of an inhalational model of invasive aspergillosis.

Steinbach WJ, Benjamin DK Jr, Trasi SA, Miller JL, Schell WA, Zaas AK, Foster WM, Perfect JR.

Med Mycol. 2004 Oct;42(5):417-25.

PMID:
15552643
18.

Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox.

Jahrling PB, Hensley LE, Martinez MJ, Leduc JW, Rubins KH, Relman DA, Huggins JW.

Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15196-200. Epub 2004 Oct 11.

19.

An apparatus for the study of airborne infection.

HENDERSON DW.

J Hyg (Lond). 1952 Mar;50(1):53-68. No abstract available.

20.

Supplemental Content

Support Center